Phase II study of dose-escalation of Regorafenib for patients with previously treated metastatic colorectal cancer.
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Interventions: Regorafenib is administered orally once daily for 21 days followed by 7 days rest. The initial dose of regorafenib is 80mg/day, and dose-escalation to 120mg or 160mg/day should be considered every two weeks. Primary outcome(s): Time to Treatment Failure Study Design: Single arm Non-randomized
创建时间：
2014-07-15
